| Acquirer | Target | Price |
|---|---|---|
| Shanghai Fosun Pharmaceutical Co. Ltd. | Gland Pharma Ltd. | $1.26 billion |
| The Sanders Trust | 3 rehabilitation hospitals | $111.5 million |
| Laboratory Corp. of America | Sequenom, Inc. | $371 million |
| Almirall, S.A. | License to tildrakizumab in Europe | $50 million |
| Chartwell Retirement Residences | Tiffin House Retirement Residence | $23.9 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
